ALYDIA HEALTH
6 recorded signal(s) across 1 type(s) · recorded between 2022-03-11 and 2026-02-27
Each entry below describes what a public filing records, on the date it was recorded. This page ranks nothing and scores nothing.
ALYDIA HEALTH, INC. recorded a security interest over 1 patent to JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT, recorded 2026-02-27.
confidence 0.95 · as of 2026-02-27 · detail · view patent
unknown · as of 30 Jan 2024 — Release status unknown — no release has been observed for this security interest (releases observed only up to 30 Jan 2024).
ALYDIA HEALTH, INC. recorded a security interest over 1 patent to JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT, recorded 2025-03-25.
confidence 0.85 · as of 2025-03-25 · detail · view patent
unknown · as of 30 Jan 2024 — Release status unknown — no release has been observed for this security interest (releases observed only up to 30 Jan 2024).
ALYDIA HEALTH, INC. recorded a security interest over 1 patent to U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT, recorded 2024-05-29.
confidence 0.95 · as of 2024-05-29 · detail · view patent
unknown · as of 30 Jan 2024 — Release status unknown — no release has been observed for this security interest (releases observed only up to 30 Jan 2024).
ALYDIA HEALTH, INC. recorded a security interest over 6 patents to U.S. BANK, NATIONAL ASSOCIATION , AS COLLATERAL AGENT, recorded 2022-03-11.
confidence 0.85 · as of 2022-03-11 · detail · view patent
active · as of 30 Jan 2024 — No release observed as of 30 Jan 2024 (release coverage ends 30 Jan 2024).
ALYDIA HEALTH, INC. recorded a security interest over 6 patents to U.S. BANK, NATIONAL ASSOCIATION , AS COLLATERAL AGENT, recorded 2022-03-11.
confidence 0.85 · as of 2022-03-11 · detail · view patent
active · as of 30 Jan 2024 — No release observed as of 30 Jan 2024 (release coverage ends 30 Jan 2024).
ALYDIA HEALTH, INC. recorded a security interest over 6 patents to JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT, recorded 2022-03-11.
confidence 0.85 · as of 2022-03-11 · detail · view patent
active · as of 30 Jan 2024 — No release observed as of 30 Jan 2024 (release coverage ends 30 Jan 2024).